{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:43:32Z","timestamp":1784346212913,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jjcc.2013.05.015","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T09:30:31Z","timestamp":1373362231000},"page":"331-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["How to understand the association between cystatin C levels and cardiovascular disease: Imbalance, counterbalance, or consequence?"],"prefix":"10.1016","volume":"62","author":[{"given":"Jo\u00e3o Victor","family":"Salgado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francival Leite","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardete Jorge","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2013.05.015_bib0005","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1590\/S0100-879X2010007500040","article-title":"Monitoring renal function: measured and estimated glomerular filtration rates \u2013 a review","volume":"43","author":"Salgado","year":"2010","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10741-011-9242-6","article-title":"A step forward in assessing kidney function and cardiovascular risk","volume":"17","author":"Lassus","year":"2012","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0015","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1161\/STROKEAHA.108.537423","article-title":"Cathepsin enzymes and cystatin C: do they play a role in positive arterial remodeling?","volume":"40","author":"Yetkin","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0020","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/HYPERTENSIONAHA.111.180935","article-title":"Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications","volume":"58","author":"Cheng","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4068\/cmj.2012.48.2.77","article-title":"Cysteinyl cathepsins: multifunctional enzymes in cardiovascular disease","volume":"48","author":"Li","year":"2012","journal-title":"Chonnam Med J"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2613.2012.00819.x","article-title":"Histopathological analysis of cellular localization of cathepsins in abdominal aortic aneurysm wall","volume":"93","author":"Lohoefer","year":"2012","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0035","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1172\/JCI7709","article-title":"Cystatin C deficiency in human atherosclerosis and aortic aneurysms","volume":"104","author":"Shi","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0040","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1046\/j.0007-1323.2001.01911.x","article-title":"Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms","volume":"88","author":"Lindholt","year":"2001","journal-title":"Br J Surg"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0045","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/01.RES.0000155964.34150.F7","article-title":"C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein e-null mice","volume":"96","author":"Sukhova","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0050","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1161\/01.ATV.0000179600.34086.7d","article-title":"Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice","volume":"25","author":"Bengtsson","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jjcc.2012.01.013","article-title":"Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications","volume":"59","author":"Puddu","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0060","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/cvr\/cvq138","article-title":"Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation","volume":"87","author":"Xie","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0065","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2353\/ajpath.2010.090381","article-title":"C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice","volume":"177","author":"Schulte","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0070","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1600-0463.2003.t01-1-apm1111110.x","article-title":"New antimicrobial cystatin C-based peptide active against gram-positive bacterial pathogens, including methicillin-resistant Staphylococcus aureus and multiresistant coagulase-negative staphylococci","volume":"111","author":"Jasir","year":"2003","journal-title":"APMIS"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0075","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.ATV.0000117180.57731.36","article-title":"Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease","volume":"24","author":"Eriksson","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/bjs.4364","article-title":"Genetic approach to the role of cysteine proteases in the expansion of abdominal aortic aneurysms","volume":"91","author":"Eriksson","year":"2004","journal-title":"Br J Surg"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1358836X0100600304","article-title":"Plasma levels of cystatin-C and mannose binding protein are not associated with risk of developing systemic atherosclerosis","volume":"6","author":"Albert","year":"2001","journal-title":"Vasc Med"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1590\/S0104-42302013000100007","article-title":"Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension","volume":"59","author":"Salgado","year":"2013","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0095","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.atherosclerosis.2010.06.021","article-title":"Predicting the risk of coronary heart disease. II. The role of novel molecular biomarkers and genetics in estimating risk, and the future of risk prediction","volume":"213","author":"Dent","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0100","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2011.02.016","article-title":"Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease","volume":"216","author":"Urbonaviciene","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0105","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/01.ATV.0000168416.74206.62","article-title":"Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events","volume":"25","author":"Loew","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0110","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCOUTCOMES.110.957696","article-title":"Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations: a meta-analysis","volume":"3","author":"Lee","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0115","first-page":"2820","article-title":"Relationship between plasma cathepsin S and cystatin C levels and coronary plaque morphology of mild to moderate lesions: an in vivo study using intravascular ultrasound","volume":"122","author":"Gu","year":"2009","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0120","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jjcc.2011.11.013","article-title":"Association of plasma cystatin C levels with angiographically documented coronary artery disease in patients of Indian origin","volume":"59","author":"Batra","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0125","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.atherosclerosis.2011.06.046","article-title":"Serum cystatin C is associated with early stage coronary atherosclerotic plaque morphology on multidetector computed tomography","volume":"218","author":"Imai","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0130","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.atherosclerosis.2007.09.022","article-title":"Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate","volume":"198","author":"Niccoli","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0135","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.mnh.0000222694.07336.92","article-title":"Update on cystatin C: new insights into the importance of mild kidney dysfunction","volume":"15","author":"Shlipak","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0140","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/j.ajkd.2011.11.042","article-title":"Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population","volume":"59","author":"Astor","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0145","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/08037050701642675","article-title":"Kidney function and thickness of carotid intima-media complex in patients with treated arterial hypertension","volume":"16","author":"Skalska","year":"2007","journal-title":"Blood Press"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0150","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/ndt\/gfp718","article-title":"Lack of independent relationship between age-related kidney function decline and carotid intima-media thickness in a healthy Chinese population","volume":"25","author":"Han","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0155","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1590\/S0066-782X2012005000083","volume":"99","author":"Monteiro","year":"2012","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00365513.2010.546879","article-title":"Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation","volume":"71","author":"Grubb","year":"2011","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0165","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s10157-010-0334-8","article-title":"Association between cystatin C and inflammation in patients with essential hypertension","volume":"14","author":"Okura","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0170","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1373\/clinchem.2009.128397","article-title":"Cystatin C and cardiovascular risk","volume":"55","author":"Taglieri","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0175","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1590\/S0104-42302011000300020","article-title":"Cystatin C and inflammatory markers in kidney transplant recipients","volume":"57","author":"Lima","year":"2011","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0180","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/oby.2011.366","article-title":"Cystatin C may better reflect the effect of obesity on renal function","volume":"20","author":"Salgado","year":"2012","journal-title":"Obesity"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0185","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0190","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1097\/HJH.0b013e328360ae2d","article-title":"Occult chronic kidney disease among persons with hypertension in the United States: data from the national health and nutrition surveys 1988\u20131994 and 1999\u20132002","volume":"31","author":"Peralta","year":"2013","journal-title":"J Hhypertens"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0195","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/eurheartj\/ehm161","article-title":"Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes","volume":"28","author":"Bassand","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0200","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/bjs.5989","article-title":"Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms","volume":"95","author":"Abisi","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0205","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/MCA.0b013e32835b6761","article-title":"Relationship of cystatin C with coronary artery disease and its severity","volume":"24","author":"Doganer","year":"2013","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0210","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2215\/CJN.02490508","article-title":"Association of visceral and subcutaneous adiposity with kidney function","volume":"3","author":"Young","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0215","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/138161211795049787","article-title":"Chronic inflammatory disorders and accelerated atherosclerosis: chronic kidney disease","volume":"17","author":"Navab","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0220","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","article-title":"Renal impairment and outcomes in heart failure: systematic review and meta-analysis","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0225","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative","volume":"31","author":"Ronco","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0230","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2478\/v10035-012-0033-0","article-title":"Serum cystatin C in relation to fat mass loss after bariatric surgery","volume":"84","author":"Sledzinski","year":"2012","journal-title":"Pol Przegl Chir"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0235","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/oby.2009.96","article-title":"Potential contribution of adipose tissue to elevated serum cystatin C in human obesity","volume":"17","author":"Naour","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0240","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2013.05.015_bib0245","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2013.7","article-title":"Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease","author":"Rule","year":"2013","journal-title":"Kidney Int"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508713001810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508713001810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:52:02Z","timestamp":1760273522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508713001810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0914508713001810"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2013.05.015","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to understand the association between cystatin C levels and cardiovascular disease: Imbalance, counterbalance, or consequence?","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2013.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}